Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Pathological processing of tau protein during the formation and maturation of neurofibrillary tangles (NFTs) includes abnormal phosphorylation, conformational changes and truncation of the C‐terminus at aspartic‐acid 421 (apoptotic product) and glutamic‐acid 391 residues. Abnormal phosphorylation and misfolding may serve as recognition signals for ubiquitin‐targeting and proteosomal processing. For this reason, we sought to determine whether ubiquitin‐targeting of tau is associated with particular tau modifications that herald specific stages of NFTs maturation in the hippocampus of Alzheimer's disease cases. Using multiple tau antibodies, we found that 30% of the total load of NFTs is ubiquitin‐associated. As reported previously ubiquitin immunoreactivity was associated with markers of phosphorylated tau in certain NFTs; however, a strong association was also found between ubiquitin and the earliest known truncation event at aspartic‐acid 421. These findings indicate that tau protein in the NFTs may be dually subjected to both apoptotic and proteosomal processing. By contrast ubiquitin immunoreactivity was poorly associated with truncation of tau at glutamic‐acid 391, suggesting that this proteolytic event may be independent of proteosomal activity. It would appear, therefore, that ubiquitin targeting of tau protein occurs at NFTs in the early and intermediate stages of the maturation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418 · cited 1×
“Insoluble tau protein (A68) fraction was isolated from the brains of AD patients in accordance to previous protocols (11, 45, 82) and subjected to dot-blot analysis with the polyclonal antibody to ubiquitin and the monoclonal antibodies to tau, Tau-46.”
MethodCaspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease
Gamblin, T. C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A. L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630428100 · Cited by 831
Self-citationBancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
Petrucelli, L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh083 · Cited by 723
Ball, M. J. (1977) · Acta Neuropathologica · doi:10.1007/bf00692056 · Cited by 639 · cited 1×
“In AD, these alterations are the result of neuronal loss, mainly produced by parenchymal accumulation of the b-amyloid peptide (Ab) into plaques and the intracellular development of neurofibrillary tangles (NFTs) in the hippocampus and cerebral cortex (5, 18, 76).”
BackgroundPerry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623 · cited 2×
“Some studies indicated that tau protein, in the form of fibrillar lesions, is labeled with ubiquitin in AD brains (53, 59, 65), while others demonstrated ubiquitin labeling of insoluble tau pools isolated from fresh AD brain tissue (19, 78).”
BackgroundResultTau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617 · cited 1×
“Conformational changes within a protein may be subjected to degradation by different proteolytic systems, including proteosomal, lysosomal and apoptotic components in an attempt to eliminate these abnormal or toxic molecules from the cytoplasm (35, 54, 71, 79).”
BackgroundUbiquitin, the proteasome and protein degradation in neuronal function and dysfunction
Tai, H.-C., & Schuman, E. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2499 · Cited by 532 · cited 1×
“The contribution of the UPS in neurodegenerative diseases, including AD, has been extensively studied (15, 63, 75, 77).”
BackgroundMonoclonal antibody PHF‐1 recognizes tau protein phosphorylated at serine residues 396 and 404
Otvos, L., Feiner, L., Lang, E., Szendrei, G. I., Goedert, M., & Lee, V. M. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390607 · Cited by 488 · cited 3×
“Antibody Epitope Host/class Source of reference Anti-ubiquitin Ubiquitin-protein conjugates Rabbit polyclonal/IgG Millipore Corp. PHF-1 Phospho-tau (Ser396,404) Mouse/IgG Otvos et al 1994 (64) Tau-C3 Truncated tau at Asp421 Mouse/IgG Gamblin et al (28) Tau-46.”
BackgroundAlonso, A. D. C., Grundke-Iqbal, I., Barra, H. S., & Iqbal, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.298 · Cited by 437
Cited by
Structure and Pathology of Tau Protein in Alzheimer Disease
Kolarova, M., García-Sierra, F., Bartos, A., Ricny, J., & Ripova, D. (2012) · International Journal of Alzheimer's Disease · doi:10.1155/2012/731526 · Cited by 468
Self-citationAlquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367
Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain
Coppieters, N., Dieriks, B. V., Lill, C., Faull, R. L. M., Curtis, M. A., & Dragunow, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.031 · Cited by 349
Ferrer, I., López-González, I., Carmona, M., Arregui, L., Dalfó, E., Torrejón-Escribano, B., Diehl, R., & Kovacs, G. G. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000030 · Cited by 217
Kontaxi, C., Piccardo, P., & Gill, A. C. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00056 · Cited by 138
Metadata
- Authors
- García‐Sierra, F., Jarero‐Basulto, J. J., Kristofikova, Z., Majer, E., Binder, L. I., & Ripova, D.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2011-10-12
- Volume
- 22
- Issue
- 2
- Pages
- 240-250
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1529133753
- Cited by
- 34
- References
- 17
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1750-3639.2011.00525.x
- The paper
- García‐Sierra, F., Jarero‐Basulto, J. J., Kristofikova, Z., Majer, E., Binder, L. I., & Ripova, D. (2012). Ubiquitin is Associated with Early Truncation of Tau Protein at Aspartic Acid421 during the Maturation of Neurofibrillary Tangles in Alzheimer's Disease. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2011.00525.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.